HEXO Corp. - CEO, Sebastien St Louis
CEO, Sebastien St Louis
Source: The Cannabis Stock
Market Herald logo

Subscribe

Be the first with the news that moves the market
  • Members of HEXO Corp’s executive management team will participate in two upcoming investor conferences
  • Sebastien St. Louis will join the Oppenheimer conference’s Cannabis panel at 12:25 p.m ET on June 15
  • Sebastien St. Louis and Trent MacDonald will participate in a fireside chat at 9:00 am ET on June 16
  • The panel and fireside chat can be accessed on HEXO’s website
  • HEXO is an award-winning licensed producer of innovative products for the global cannabis market
  • HEXO Corp. (HEXO) is down 0.25 per cent, trading at C$7.99 per share at 1:25 pm ET

Members of HEXO Corp’s executive management team will participate in two upcoming investor conferences.

Sebastien St. Louis, Chief Executive Officer, and Trent MacDonald, Chief Financial Officer, will participate in virtual conferences hosted by Oppenheimer and Cantor Fitzgerald.

  • Tuesday, June 15, 2021 – Oppenheimer Consumer Growth & E-Commerce Conference:
    St-Louis will join the Cannabis panel at 12:25 p.m. Eastern Time, moderated by Rupesh Parikh, Managing Director and Senior Research Analyst covering Food, Grocery & Consumer Products at Oppenheimer.
  • Wednesday, June 16, 2021 – Cantor Fitzgerald Virtual Canadian LPs Cannabis Forum:
    St-Louis and MacDonald will participate in a fireside chat at 9:00 a.m. Eastern Time, hosted by Pablo Zuanic, lead Research Analyst on Cannabis at Cantor Fitzgerald.

The panel and fireside chat can be accessed via HEXO’s Events Calendar.

HEXO is an award-winning licensed producer of innovative products for the global cannabis market. HEXO serves the Canadian recreational market with a brand portfolio including HEXO, UP Cannabis, Original Stash, Bake Sale, Namaste, and REUP brands, and the medical market in Canada, Israel and Malta.

HEXO Corp. (HEXO) is down 0.25 per cent, trading at C$7.99 per share at 1:25 pm ET.

More From The Market Herald

" Revive (CSE:RVV) gets FDA OK for Bucillamine trials to treat COVID-19

Revive Therapeutics (RVV), a cannabis and psychedelic healthcare company has received feedback from the U.S. FDA to help advance Bucillamine.

" West Island Brands (CSE:WIB) releases Q1 financial results

West Island Brands (WIB) has released unaudited first quarter 2022 financial results.

" Sweet Earth (CSE:SE) signs LOI to acquire strategic targets from ST Group

Sweet Earth Holdings (SE) has signed an LOI with ST Group to explore the amalgamation of certain partner assets and companies into Sweet

" Vibe Growth (CSE:VIBE) obtains approval for greenhouse cultivation license

Vibe Growth (VIBE) has been granted a commercial cannabis cultivation license by the State of California’s Department of Cannabis Control.